KAIST-Yonsei mTORC1 mechanism discovery
Analysis based on 6 articles · First reported Jul 26, 2026 · Last updated Jul 27, 2026
The discovery may lead to development of more targeted cancer therapies, potentially benefiting biotechnology and pharmaceutical companies focused on oncology. However, the research is at an early stage, and immediate market impact is limited.
Researchers at KAIST and Yonsei University have uncovered the molecular mechanism by which amino acid signals activate the mTORC1 growth switch. The study, published in Nature Communications on June 11, 2026, reveals that upon nutrient stimulation, LARS1 is phosphorylated and released from the multi-tRNA synthetase complex (MSC), subsequently activating mTORC1. The team used cryo-electron microscopy to determine the structure of the LARS1:IARS1 complex and engineered phosphomimetic LARS1 variants that enhanced mTORC1 activity. This discovery provides a potential upstream target for anticancer therapies that could avoid the side effects of direct mTORC1 inhibition.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard